Darifenacin 13668-0202
Product NDC
13668-0202- Manufacturer
- Torrent Pharmaceuticals Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- November 18, 2016
- Listing Expires
- December 31, 2027
- Application
- ANDA205209
Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Darifenacin Hydrobromide | 7.5 mg/1 |
Drug Class
Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]
Packaging Options(3)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-05)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-30)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (13668-202-90)